(Q37121353)

18 August 2017

1 reference

title

Lupus: improving long-term prognosis (English)

1 reference

18 August 2017

1

A Doria

1 reference

18 August 2017

C Briani

2

1 reference

18 August 2017

1 March 2008

1 reference

18 August 2017

1 reference

18 August 2017

17

1 reference

18 August 2017

3

1 reference

18 August 2017

166-170

1 reference

Exploring new territory: considering the future

18 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F0961203307087612

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307087612

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307087612

Environment and systemic lupus erythematosus: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307087612

Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307087612

Exploring the links between systemic lupus erythematosus and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307087612

An Official ATS Workshop Summary: Recent advances and future directions in pneumocystis pneumonia (PCP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307087612

Infections in the immunocompromised rheumatologic patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307087612

Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307087612

Prevention of hepatitis B reactivation with lamivudine in hepatitis B virus carriers with hematologic malignancies treated with chemotherapy--a prospective case series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307087612

Cyclosporine A for the treatment of autoimmune disorders in HCV infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307087612

Mycophenolic acid inhibits hepatitis C virus replication and acts in synergy with cyclosporin A and interferon-alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307087612

Accelerated atherosclerosis in autoimmune rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307087612

Inflammation and accelerated atherosclerosis: basic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307087612

Systemic lupus erythematosus, atherosclerosis, and autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307087612

OxLDL/beta2GPI-anti-oxLDL/beta2GPI complex and atherosclerosis in SLE patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307087612

Premature coronary disease in systemic lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307087612

Prevention of cardiovascular disease in systemic lupus erythematosus--proposed guidelines for risk factor management

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307087612

Mycophenolate mofetil (MMF): firing at the atherosclerotic plaque from different angles?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307087612

Adding chloroquine to conventional treatment for glioblastoma multiforme: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307087612

High-throughput measurement of the Tp53 response to anticancer drugs and random compounds using a stably integrated Tp53-responsive luciferase reporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307087612

Therapy of glioblastoma multiforme improved by the antimutagenic chloroquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307087612

Antimalarials may influence the risk of malignancy in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307087612

Are we at a stage to predict autoimmune rheumatic diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307087612

Photosensitivity in systemic lupus erythematosus: laboratory testing of ARA/ACR definition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307087612

Cigarette smoking and systemic lupus erythematosus: a smoking gun?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307087612

Association of smoking with dsDNA autoantibody production in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307087612

Vitamin D and autoimmunity: new aetiological and therapeutic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307087612

TLR9 signals after translocating from the ER to CpG DNA in the lysosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307087612

Antiphospholipid antibodies (aPL) in systemic lupus erythematosus. Are they specific tools for the diagnosis of aPL syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307087612

Management of antiphospholipid antibody syndrome: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307087612

Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307087612

A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307087612

Mycophenolate mofetil in lupus glomerulonephritis: effectiveness and tolerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307087612

Mycophenolate mofetil: what is its place in the treatment of autoimmune rheumatic diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307087612

Drug-induced lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307087612

21 January 2018

Identifiers

DOI

10.1177/0961203307087612

1 reference

18 August 2017

1 reference

PubMed ID

18372355